Lv1
26 积分 2025-12-12 加入
FRI-204 FB7033: A novel siRNA dual-targeting Hydroxysteroid 17-beta Dehydrogenase 13 (HSD17β13) and cell death-inducing DFF45-like effector B (CIDEB) exhibits potential for treatment of metabolic dysfunction-associated steatohepatitis (MASH)
6天前
已关闭
A novel NAMPT activator ameliorates obesity by repressing ACSL1-dependent lipid synthesis
1个月前
已完结
Discovery of a Nicotinamide Phosphoribosyltransferase (NAMPT) Activator for Improving Muscle Function and Alleviating Fatigue
1个月前
已完结
Proprotein convertase subtilisin/kexin Type 9 inhibitors: past, present, and future
1个月前
已完结
Development of cyclopeptide inhibitors specifically disrupting FXR–coactivator interaction in the intestine as a novel therapeutic strategy for MASH
2个月前
已完结
A High-Potency Protein That Normalizes Body Weight in DIO Mice through Triple Agonism at FGF21, GLP1, and GIP Receptors
3个月前
已完结
Somatic loss-of-function mutations in CIDEB reduce hepatic steatosis by increasing lipolysis and fatty acid oxidation
3个月前
已完结
Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity target
5个月前
已完结
A review on NLRP3 inflammasome modulation by animal venom proteins/peptides: mechanisms and therapeutic insights
5个月前
已完结
Strategic Mutations in Designer Native Peptides Combat NLRP3 Inflammasome Activation in Neurodegenerative Disorders
5个月前
已完结
皖公网安备34019202002308
